The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Goff, D. C.
* Articles by Coyle, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Goff, D. C.
* Articles by Coyle, J.
Related Collections
* Neurotransmitters
* Schizophrenia Spectrum Disorders
* Symptoms/Dimensions
Am J Psychiatry 161:1705-1708, September 2004
© 2004 American Psychiatric Association


Brief Report

Folate, Homocysteine, and Negative Symptoms in Schizophrenia

Donald C. Goff, M.D., Teodoro Bottiglieri, Ph.D., Erland Arning, Ph.D., Vivian Shih, M.D., Oliver Freudenreich, M.D., A. Eden Evins, M.D., David C. Henderson, M.D., Lee Baer, Ph.D., and Joseph Coyle, M.D.

OBJECTIVE: Because glutamate carboxypeptidase II (GCPII) regulates both folate absorption and activation of N-methyl-D-aspartic acid receptors, the authors examined relationships between serum folate concentrations and clinical symptoms in schizophrenia patients. METHOD: For 91 outpatients with schizophrenia, clinical assessments were performed and serum folate, homocysteine, B12, glycine, and serine concentrations were measured. RESULTS: Serum folate concentrations were significantly lower than in a representative sample from the Framingham Offspring Study. Folate concentration correlated inversely with the Scale for Assessment of Negative Symptoms total score and was lower in patients with the deficit syndrome than in nondeficit patients. Homocysteine concentration correlated with the severity of extrapyramidal symptoms. CONCLUSIONS: These findings could reflect several possible mechanisms, including low dietary intake of folate, low GCPII activity, cigarette smoking, and the involvement of folate in the synthesis of neurotransmitters. Additional studies are needed to clarify these findings.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
A. S. Brown, T. Bottiglieri, C. A. Schaefer, C. P. Quesenberry Jr, L. Liu, M. Bresnahan, and E. S. Susser
Elevated Prenatal Homocysteine Levels as a Risk Factor for Schizophrenia
Arch Gen Psychiatry, January 1, 2007; 64(1): 31 - 39.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
C. O'DONNELL and T. STEPHENS
The Significance of Homocysteine Levels in Schizophrenia
Am J Psychiatry, July 1, 2005; 162(7): 1387 - 1388.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org